We also observed that exposure of melanoma cells to melphalan induced expression of immune-related markers such as MHC class I (HLA-ABC), which may be relevant for the ability of CD8+ T cells to detect and eliminate malignant cells, and PD-L1 that serves to target PD-1 and thus may limit the T cell-mediated destruction of healthy tissue. Here, CD8A is linked to melanoma.